Evidence map›Paper›PMID 15471891›Full record

GuidelineAnnals of the rheumatic diseases2005

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

W Zhang, M Doherty, N Arden, B Bannwarth, J Bijlsma, K-P Gunther, H J Hauselmann, G Herrero-Beaumont, K Jordan, P Kaklamanis and 14 more

3 registry-linked trialsOpen access · bronzeAbstract readGuidelinePractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Annals of the rheumatic diseases, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 258 papers, 21 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
258citing papers in PubMed, 21 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00604539 phase3completednot on this mapstarted 2008, after this paper: background citation

Study of the Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee

TypeinterventionalSponsorBioibericaRan2008Enrolled70ConditionsSynovitis, Osteoarthritis, Joint Diseases, Muskuloskeletal DiseasesArmsChondroitin sulphate (Condrosan), Placebo
NCT02800759 nacompletednot on this mapstarted 2013, after this paper: background citation

The Minimal Effective Dose of Cis-9-cetylmyristoleate (CMO) in Persons Presenting With Knee Joint Pain

TypeinterventionalSponsorSeoul National UniversityRan2013 to 2014Enrolled28ConditionsKnee Pain IntermittentArmsJOINTRUS®, 80% dose of JOINTRUS®, 62.4% dose of JOINTRUS®, Starch 100%
NCT04018690 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Project Arthritis Recovering Quality of Life Through Education - Hip

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2019 to 2020Enrolled48ConditionsHip OsteoarthritisArmsPatients will be submitted to needle lavage, followed by the injection of 3mL of hylan and 1 mL of ropivacaine, Patients will be submitted to needle lavage, followed by the injection of 0,5mL triamcinolone (10mg) and 1 mL of ropivacaine,
3 · Its place in the literature

Who cites it

258 citing papers in PubMed, 21 syntheses or guidelines pooled it, 783 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Routine-data-compatible quality indicators for the ambulatory care of osteoarthritis of the knee and hip: A systematic review.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Paracetamol versus placebo for knee and hip osteoarthritis.The Cochrane database of systematic reviews · 2019
    Pooled it
  11. Acupuncture for hip osteoarthritis.The Cochrane database of systematic reviews · 2018
    Pooled it
  12. Pooled it
  13. Guideline
  14. Intra-articular facet joint injections for low back pain: a systematic review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2016
    Pooled it
  15. Guideline
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

198 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 14 countries.

W ZhangAcademic Rheumatology, University of Nottingham, UK.
M Doherty
N Arden
B Bannwarth
J Bijlsma
K-P Gunther
H J Hauselmann
G Herrero-Beaumont
K Jordan
P Kaklamanis
B Leeb
M Lequesne
S Lohmander
B Mazieres
E Martin-Mola
K Pavelka
A Pendleton
L Punzi
B Swoboda
R Varatojo
G Verbruggen
I Zimmermann-Gorska
M Dougados
EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Southampton General Hospital · GBUniversity of Nottingham · GBCommunity Health Systems - Lutheran Hospital · USDimos Athinaion Epicheirisi Michanografisis (Greece) · GRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGhent University · BEHôpital Cochin · FRHôpital de la Conception · FRHôpital Pellegrin · FRHôpital Rangueil · FRHospital Universitario La Paz · ESInstitute of Rheumatology · CZLund University · SEPoznan University of Medical Sciences · PLTechnische Universität Dresden · DEUniversity of Lisbon · PTUniversity of Padua · ITUniversity of Ulster · GBUniversity of Zurich · CHUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop evidence based recommendations for the management of hip osteoarthritis (OA).

methodsThe multidisciplinary guideline development group comprised 18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 European countries. Each participant contributed up to 10 propositions describing key clinical aspects of hip OA management. Ten final recommendations were agreed using a Delphi consensus approach. Medline, Embase, CINAHL, Cochrane Library, and HTA reports were searched systematically to obtain research evidence for each proposition. Where possible, outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. Effect size, rate ratio, number needed to treat, and incremental cost effectiveness ratio were calculated. The quality of evidence was categorised according to the evidence hierarchy. The strength of recommendation was assessed using the traditional A-D grading scale and a visual analogue scale.

resultsTen key treatment propositions were generated through three Delphi rounds. They included 21 interventions, such as paracetamol, NSAIDs, symptomatic slow acting disease modifying drugs, opioids, intra-articular steroids, non-pharmacological treatment, total hip replacement, osteotomy, and two general propositions. 461 studies were identified from the literature search for the proposed interventions of efficacy, side effects, and cost effectiveness. Research evidence supported 15 interventions in the treatment of hip OA. Evidence specific for the hip was strikingly lacking. Strength of recommendation varied according to category of research evidence and expert opinion.

conclusionTen key recommendations for the treatment of hip OA were developed based on research evidence and expert consensus. The effectiveness and cost effectiveness of these recommendations were evaluated and the strength of recommendation was scored.

Indexed as

AcetaminophenAdultAgedAged, 80 and overAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsArthroplasty, Replacement, HipCost-Benefit AnalysisDelphi TechniqueEvidence-Based MedicineExerciseFemaleHumansMaleMiddle AgedAcetaminophenAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAntirheumatic Agents

Identifiers

PMID15471891
PMCPMC1755499
OpenAlexW4248226706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.